C. Lepage, L. Dahan, J.-L. Legoux, K. Le Malicot, R. Guimbaud, et al.. REMINET : A European, Multicenter, Phase II/III Randomized Double-Blind, Placebo-Controlled Study Evaluating Lanreotide As Maintenance Therapy after First-Line Treatment in Patients with Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors .
The 14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelone, Spain. pp.187 (J8).
⟨hal-01664217⟩ 
